Skip Navigation



NDT Advance Access published online on June 7, 2005
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfh925
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/7/1315    most recent
gfh925v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Serra, A. L.
Right arrow Articles by Wüthrich, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serra, A. L.
Right arrow Articles by Wüthrich, R. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Rapid Communication

Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism

Andreas L. Serra 1*, Albin A. Schwarz 1, Franziska H. Wick 1, Hans-Peter Marti 1, and Rudolf P. Wüthrich 1

1 Division of Nephrology, University Hospital, Rämistrasse 100, 8091 Zürich, Switzerland

* To whom correspondence should be addressed.
Andreas L. Serra, E-mail: andreas.serra{at}usz.ch



  Abstract

Background. Cinacalcet lowers plasma parathyroid hormone (PTH) levels in primary and secondary hyperparathyroidism. The efficacy and safety of cinacalcet have not been examined in renal transplant patients with persistent hyperparathyroidism. The aim of this study was to evaluate the effect of cinacalcet as a novel therapy for the management of such patients.

Methods. Eleven renal allograft recipients with persistent hyperparathyroidism were treated with cinacalcet. The total study time was 10 weeks. Individual cinacalcet doses were adjusted to obtain a serum calcium in the predefined normal target range of 2.10-2.60 mmol/l.

Results. Serum calcium decreased significantly from 2.73±0.05 mmol/l to 2.44±0.05 and 2.42± 0.04 mmol/l after 2 and 10 weeks of treatment, respectively. All patients reached the target range rapidly and remained normocalcaemic throughout the study. Serum PTH significantly decreased 16.1 and 21.8% at study weeks 2 and 10, respectively, compared with week 0. Serum phosphate increased. Renal function remained stable and no allograft rejection was observed. From weeks 2 to 10, daily cinacalcet doses administered were 30 mg (n = 8), 15 mg (n = 1) and 60 mg (n = 1), respectively.

Conclusion. Cinacalcet was effective in correcting the hypercalcaemia associated with persistent hyperparathyroidism after renal transplantation. It appears to be safe. Thus, cinacalcet represents a promising alternative for parathyroidectomy in these patients.

Keywords: calcium; cinacalcet; hypercalcaemia; hyperparathyroidism; kidney transplantation; PTH.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
N. Kamar, I. Gennero, L. Spataru, L. Esposito, J. Guitard, L. Lavayssiere, O. Cointault, P. Gandia, D. Durand, and L. Rostaing
Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose
Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3720 - 3726.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. Falck, N. T. Vethe, A. Asberg, K. Midtvedt, S. Bergan, J. L. E. Reubsaet, and H. Holdaas
Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients
Nephrol. Dial. Transplant., March 1, 2008; 23(3): 1048 - 1053.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
U. Kunzendorf, B. K. Kramer, W. Arns, J. Braun, J. Grossmann, F. Pietruck, H. Schmidt-Gayk, A. Schwarz, E. Ziegler, H. Sperschneider, et al.
Bone disease after renal transplantation
Nephrol. Dial. Transplant., February 1, 2008; 23(2): 450 - 458.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Fukagawa, S. Yumita, T. Akizawa, E. Uchida, Y. Tsukamoto, M. Iwasaki, S. Koshikawa, and KRN1493 study group
Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favourable control of the serum phosphorus and calcium levels in Japanese dialysis patients
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 328 - 335.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
T. B. Drueke, D. Martin, and M. Rodriguez
Reply
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 408 - 409.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Fukagawa and M. Taniguchi
Can calcimimetics inhibit nodular hyperplasia of parathyroid glands?
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 407 - 408.
[Full Text] [PDF]

Home page
 NDT PlusHome page
M. Chonchol and R. P. Wuthrich
Potential Future Uses of Calcimimetics in Patients with Chronic Kidney Disease
NDT Plus, January 1, 2008; 1(suppl_1): i36 - i41.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. E. Kruse, U. Eisenberger, F. J. Frey, and M. G. Mohaupt
Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism
Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2362 - 2365.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
C. Lomonte, M. Antonelli, N. Losurdo, G. Marchio, B. Giammaria, and C. Basile
Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy
Nephrol. Dial. Transplant., July 1, 2007; 22(7): 2056 - 2062.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. Evenepoel, K. Claes, D. R. Kuypers, F. Debruyne, and Y. Vanrenterghem
Parathyroidectomy after successful kidney transplantation: a single centre study
Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1730 - 1737.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. L. Serra, R. Savoca, A. R. Huber, U. Hepp, A. Delsignore, M. Hersberger, and R. P. Wuthrich
Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients
Nephrol. Dial. Transplant., February 1, 2007; 22(2): 577 - 583.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Schwarz, G. Rustien, S. Merkel, J. Radermacher, and H. Haller
Decreased renal transplant function after parathyroidectomy
Nephrol. Dial. Transplant., February 1, 2007; 22(2): 584 - 591.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
J. R. Weisinger, R. G. Carlini, E. Rojas, and E. Bellorin-Font
Bone Disease after Renal Transplantation
Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1300 - 1313.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
N. Velasco, M. S. MacGregor, A. Innes, and I. G. MacKay
Successful treatment of calciphylaxis with cinacalcet--an alternative to parathyroidectomy?
Nephrol. Dial. Transplant., July 1, 2006; 21(7): 1999 - 2004.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
E. Lewin and K. Olgaard
Parathyroidectomy vs calcimimetics for treatment of persistent hyperparathyroidism after kidney transplantation
Nephrol. Dial. Transplant., July 1, 2006; 21(7): 1766 - 1769.
[Full Text] [PDF]

Home page
 CJASNHome page
A. Djamali, M. Samaniego, B. Muth, R. Muehrer, R. M. Hofmann, J. Pirsch, A. Howard, G. Mourad, and B. N. Becker
Medical Care of Kidney Transplant Recipients after the First Posttransplant Year
Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 623 - 640.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
N. Leonard and J. H. Brown
Persistent and symptomatic post-transplant hyperparathyroidism: a dramatic response to cinacalcet
Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1736 - 1736.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
H. Boulanger, J. P. Haymann, B. Fouqueray, R. Mansouri, F. Metiver, E. Sarfati, and D. Glotz
Reply
Nephrol. Dial. Transplant., March 1, 2006; 21(3): 824 - 825.
[Full Text] [PDF]

Home page
 CJASNHome page
T. R. Srinivas, J. D. Schold, K. L. Womer, B. Kaplan, R. J. Howard, C. M. Bucci, and H.-U. Meier-Kriesche
Improvement in Hypercalcemia with Cinacalcet after Kidney Transplantation
Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 323 - 326.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
H. Boulanger, J. P. Haymann, B. Fouqueray, R. Mansouri, F. Metivier, E. Sarfati, and D. Glotz
Therapeutic failure of cinacalcet in a renal transplant patient presenting hyperparathyroidism with severe hypercalcaemia
Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2865 - 2865.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.